| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |